Aktiespot

Shenzhen Neptunus Interlong Bio-technique Company Limited (NEP INTERLONG) Aktie

8329.HK

HK$0.105-0.005 (-4.55%)
Chart wird geladen...

NEP INTERLONG

Eröffnung0.104
Hoch0.107
Tief0.092
Volumen10k
P/EN/A
Marktkapitalisierung176.19M
52-Wochen-Hoch0.209
52-Wochen-Tief0.092
Durchschn. Volumen319.17k
Dividende4.23%
Beta-0.13
EPS-0.030

Über Shenzhen Neptunus Interlong Bio-technique Company Limited (NEP INTERLONG) Aktie

Shenzhen Neptunus Interlong Bio-technique Company Limited, together with its subsidiaries, engages in the research and development, manufacturing, and selling of medicines and medical devices in the People's Republic of China. It operates through two segments, Manufacturing and Selling of medicines and medical devices; and Sales and Distribution of medicines and healthcare products, and medical devices. The company offers medicines for various therapeutic areas, including oncology, cardiovascular system, respiratory system, digestive system, and mental diseases. It is also involved in the purchase, sale, and distribution of medicines and healthcare food products; and research and development of biological technology business. Shenzhen Neptunus Interlong Bio-technique Company Limited was incorporated in 2002 and is based in Quarry Bay, Hong Kong. Shenzhen Neptunus Interlong Bio-technique Company Limited operates as a subsidiary of Shenzhen Neptunus Bio-engineering Company Limited.

Unternehmensinformationen

Börse: HKSE (HKG)
Sektor: Sundhed
Branche: Lægemiddelproducenter – Special og generisk
Adresse:
One Taikoo Place
Quarry Bay, Hong Kong

Analystenempfehlungen

Diese Übersicht gibt einen schnellen Einblick, wie Analysten das Aktienpotenzial basierend auf ihren neuesten Analysen und Kurszielen bewerten.

Niedrigstes Kursziel
Durchschnittliches Kursziel
Median Kursziel
Höchstes Kursziel

Andere sehen auch: